![]() |
|||
|
|
| UPDATE: May 2009 | MW: 425.04 | MF: C18H33ClN2O5S |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | mouse
lethal dose (50 percent kill): 1,100 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
intramuscular | rat
lethal dose (50 percent kill): 3,500 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
intraperitoneal | mammal (species unspecified)
lethal dose (50 percent kill): 262 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
intraperitoneal | mouse
lethal dose (50 percent kill): 361 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
intraperitoneal | rat
lethal dose (50 percent kill): 745 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
intravenous | mammal (species unspecified)
lethal dose (50 percent kill): 143 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
intravenous | mouse
lethal dose (50 percent kill): 245 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
intravenous | rabbit
lowest published toxic dose: 5 mg/kg
|
Vascular: BP lowering not characterized in autonomic section
|
VCVPS* -,408,1998
|
oral | hamster
lowest published lethal dose: 1 mg/kg
|
Gastrointestinal: Other changes
|
ARZNAD 34,794,1984
|
oral | mammal (species unspecified)
lethal dose (50 percent kill): 5,000 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
oral | mouse
lethal dose (50 percent kill): 2,540 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
oral | rat
lethal dose (50 percent kill): 2,190 mg/kg
|
N/R
|
VCVPS* -,408,1998
|
oral | rabbit
lowest published lethal dose: 1 mg/kg
|
N/R
|
RMVEAG 156,915,1980
|
subcutaneous | rat
lethal dose (50 percent kill): 2,618 mg/kg
|
N/R
|
TXAPA9 18,185,1971
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | human
lowest published toxic dose: 89.6 mg/kg/7 day- intermittent
|
Gastrointestinal: Hypermotility, diarrhea | Gastrointestinal: Nausea or vomiting
VCVPS* -,408,1998
|
oral | human
lowest published toxic dose: 60.2 mg/kg/7 day- intermittent
|
Gastrointestinal: Hypermotility, diarrhea | Gastrointestinal: Other changes
VCVPS* -,409,1998
|
oral | human
lowest published toxic dose: 90 mg/kg/7 day- intermittent
|
Skin: After systemic exposure: Dermatitis, allergic
|
BJDEAZ 146,643,2002
|
oral | rat
lowest published toxic dose: 4,200 mg/kg/2 week- intermittent
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
VCVPS* -,408,1998
|
oral | rat
lowest published toxic dose: 210 mg/kg/3 week- intermittent
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
VCVPS* -,408,1998
|
oral | rat
lowest published toxic dose: 210 mg/kg/3 week- intermittent
|
Blood: Change in clotting factors
|
VCVPS* -,408,1998
|
oral | rabbit
lowest published toxic dose: 330 mg/kg/33 day- intermittent
|
Gastrointestinal: Other changes
|
ANTBAL 28,18,1983
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
MUREAV 488,151,2001
|
TOXICOLOGY REVIEW
|
|
TOLED5 142,207,2003
|
TOXICOLOGY REVIEW
|
|
EMMUEG 43,143,2004
|
TOXICOLOGY REVIEW
|
|
EJIME* 17,529,2006
|
TOXICOLOGY REVIEW
|
|
DIMON* 39,678,1993
|
TOXICOLOGY REVIEW
|
|
HPCQA4 38,527,2007
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X3191 |
Number of Industries 1; Total Number of Facilities 445; Number of Occupations 7; Total Number of Employees Exposed 21,575; Total Number of Female Employees Exposed 17,442 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
ANTBAL
|
Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH.
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
BJDEAZ
|
British Journal of Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.63-
1951-
|
DIMON*
|
Disease-a Month (Chicago : Year Book Publishers) V. 24- 1978-
|
EJIME*
|
European Journal of Internal Medicine: The Official Journal of the European Federation of
Internal Medicine (EFIM) (Elsevier) V.10- 1999-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
HPCQA4
|
Human Pathology. (W.B. Saunders Co., W. Washington Sq., Philadelphia, PA 19105) V.1- 1970-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
RMVEAG
|
Recueil de Medecine Veterinaire. (Masson Pub. USA, Inc., Year Book Medical Pub., 35 E. Wacker
Dr., Chicago IL 60601) V.1- 1824-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
VCVPS*
|
"Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances.
Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998.
|
| |